"10.1371_journal.pmed.1001338","plos medicine","2012-11-13T00:00:00Z","Peter Recknagel; Falk A Gonnert; Martin Westermann; Sandro Lambeck; Amelie Lupp; Alain Rudiger; Alex Dyson; Jane E Carré; Andreas Kortgen; Christoph Krafft; Jürgen Popp; Christoph Sponholz; Valentin Fuhrmann; Ingrid Hilger; Ralf A Claus; Niels C Riedemann; Reinhard Wetzker; Mervyn Singer; Michael Trauner; Michael Bauer","Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany; Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, United Kingdom; Electron Microscopy Center, Jena University Hospital, Jena, Germany; Department of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany; Institute of Photonic Technology, Jena, Germany; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany; Department of Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, Jena, Germany","¶ These authors are joint senior authors on this work.","The authors declare that a patent has been filed regarding the use of bile acids for the diagnosis of sepsis (MB). MS is a member of the Editorial Board of PLOS Medicine. The authors declare that no other competing interests exist.","2012","11","Peter Recknagel","PR",20,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
